Pda Technical Report 82 Pdf

Let’s move from theory to practice. Here are three real-world scenarios where PDA Technical Report 82 is directly applied.

Problem: Your process has three filtration steps (clarification, low bioburden, sterile). You want to eliminate the sterile filter and rely on low bioburden + viral clearance. TR-82 Solution: Chapter 6 provides a “Risk-Based Filtration Train” diagram. It shows how to validate aseptic connections and single-use systems so that a low bioburden filter (0.45 micron) is acceptable, provided the final bulk is not terminally sterilized.

PDA Technical Reports are peer-reviewed, consensus-based documents developed by subject matter experts from industry, regulatory agencies (like the FDA and EMA), and academia. TR 82 is specifically dedicated to addressing LER. pda technical report 82 pdf

Full Title: PDA Technical Report No. 82 (TR 82): Low Endotoxin Recovery

Publication Date: 2011 (with supplementary updates and case studies in subsequent years) Let’s move from theory to practice

Purpose: To provide a systematic framework for:

| Misconception | TR 82 Clarification | |---------------|----------------------| | "LER means my LAL test is broken." | No—LER is a product interaction phenomenon, not a test failure. | | "All LER is harmless." | False. Some LER masks pyrogenic endotoxins. Requires case-by-case risk assessment. | | "Just use rFC instead of LAL to fix LER." | Both LAL and rFC suffer equally from LER because the mechanism is biochemical masking, not reagent specificity. | | "The FDA rejects products with LER." | Incorrect. The FDA accepts products with LER if properly documented and justified using TR 82 principles. | If recovery falls below 50% at any time

The report offers hard data on pressure limits, flow rates, and filtration time. It warns that scaling up from lab-scale disc filters to manufacturing-scale cartridges often fails without the guidelines provided in TR-82.

TR 82 emphasizes the kinetics of thermal destruction. Unlike sterilization (which follows a logarithmic death curve for bacteria), depyrogenation requires the physical degradation of endotoxin molecules. The report discusses the calculation of D-values (time required to reduce endotoxin by 90% at a specific temperature) and F-values (accumulated lethality).

As per TR 82 Section 7, add a known quantity of endotoxin (e.g., 100 EU/mL) to your product at time zero. Test for recovery at:

If recovery falls below 50% at any time point without a parallel drop in a control buffer → LER is confirmed.